ScienceDirect, 2026 #Ophthalmology #RetinalResearch #Biologics #3Rs To view or add a comment, sign in The "Animal-First" era of drug development just hit a massive turning point
The better way to compare research vendors is to look at price plus quality signals: vendor history, COA access, lot-level testing, shipping speed, payment options, and whether the page avoids human-use claims
Looking at the pipelines set out by major manufacturers, The Pharmaceutical Journal highlights some of the most promising and most novel approaches that could be rolled out to patients in the years to come, unpacking how they work and what benefits they could offer
Almost two years ago, weight-loss drugs were all the rage
body care for firming and hydration